Gilead Sciences Down Over 4%, on Pace for Largest Percent Decrease Since July 2025 — Data Talk
Gilead Sciences, Inc. (GILD) is currently at $129.33, down $5.51 or 4.09%
--Would be lowest close since July 1, 2026, when it closed at $125.97
--On pace for largest percent decrease since July 11, 2025, when it fell 4.28%
--Currently down four of the past five days
--Currently down three consecutive days; down 5.16% over this period
--Worst three day stretch since the three days ending June 10, 2026, when it fell 5.95%
--Down 1.48% this week; worst weekly performance since the week ending June 12, 2026, when it fell 2.76%
--Up 2.37% month-to-date
--Up 5.37% year-to-date
--Down 16.99% from its all-time closing high of $155.80 on Feb. 11, 2026
--Up 17.96% from 52 weeks ago (July 11, 2025), when it closed at $109.64
--Down 16.99% from its 52-week closing high of $155.80 on Feb. 11, 2026
--Up 19.51% from its 52-week closing low of $108.22 on July 18, 2025
--Traded as low as $129.27
--Down 4.13% at today's intraday low; largest intraday percent decrease since Nov. 7, 2025, when it fell as much as 4.75%
--Third worst performer in the S&P 500 today
--Third worst performer in the Nasdaq 100 today
All data as of 1:05:03 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
July 10, 2026 13:30 ET (17:30 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
